TY - JOUR
T1 - A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
AU - PRECEDENT Study Group
AU - Potter, Shelley
AU - Avery, Kerry
AU - Ahmed, Rosina
AU - de Boniface, Jana
AU - Chatterjee, Sanjoy
AU - Dodwell, David
AU - Dubsky, Peter
AU - Federmann, Jingjing
AU - Finestone, Sandra
AU - Gnant, Michael
AU - Hlauschek, Dominik
AU - Iwata, Hiroji
AU - Jiang, Michael Y.
AU - Kaidar-Person, Orit
AU - Lee, Han Byoel
AU - MacKenzie, Mairead
AU - Meyn, Anne
AU - Poortmans, Philip
AU - Poulakaki, Fiorita
AU - Richardson, Andrea L.
AU - Sepulveda, Karla A.
AU - Spillane, Andrew J.
AU - Thompson, Alastair M.
AU - Werutsky, Gustavo
AU - Wittmann, Philipp
AU - Wright, Jean L.
AU - Zdenkowski, Nicholas
AU - Cowan, Katherine
AU - McIntosh, Stuart A.
AU - Zope, Anagha
AU - Zivkovic, Marija
AU - Zeko, Amanda
AU - Cobos, Gastón Zatta
AU - Žatecký, Jan
AU - Youn, Hyun Jo
AU - Yiallourou, Anneza
AU - Yeh, Janice
AU - Kumar, Sanjay
AU - Wyld, Lynda
AU - Wong, Stephanie
AU - Wiebe, Ericka
AU - Warnberg, Fredrik
AU - Wapnir, Irene
AU - Walker, Melanie
AU - Wadasadawala, Tabassum
AU - Voutsadakis, Ioannis
AU - Vohra, Lubna
AU - Vidal-Sicart, Sergi
AU - Venkitaraman, Ramachandran
AU - Velu, Umesh
AU - Vázquez-Barreiro, Beatriz
AU - Vandermeulen, Ad
AU - Van Maaren, Marissa C.
AU - Duijnhoven, Frederieke Van
AU - Hage, Jos Van Der
AU - Berkmortel, Franchette Van Den
AU - Valachis, Antonis
AU - Vaidya, Jayant
AU - Ueno, Takayuki
AU - Tvedskov, Tove
AU - Tsoutsou, Pelagia
AU - Tsiatas, Marinos
AU - Thorat, Mangesh
AU - Thomson, Jacqui
AU - Thaweerat, Wajana
AU - Tezcanli, Evrim
AU - Liutti, Vitor Teixeira
AU - Taylor, Donatienne
AU - Tavoletta, Maria Saveria
AU - Tandon, Megha
AU - Swinden, Michael
AU - Susini, Tommaso
AU - Suga, Yisihak
AU - Stuart, Kirsty
AU - Stranzl, Heidi
AU - Spanheimer, Philip
AU - De Celis, Enrique Soto Perez
AU - Snook, Kylie
AU - Smith, Fiona
AU - Sirohi, Bhawana
AU - Simcock, Richard
AU - Silva, Aumilto
AU - Sidiropoulou, Zacharoula
AU - Sibbering, Mark
AU - Shoshkova, Mery
AU - Shetty, Preethi S.
AU - Shenoy, Shashank
AU - Sharma, Shelly
AU - Sharawy, Iman
AU - Shanthilal, Mukesh
AU - Setakornnukul, Jiraporn
AU - Serra, Margherita
AU - Scardina, Lorenzo
AU - Savva, Constantinos
AU - Sánchez-Méndez, Jose I.
AU - Salinas, Jorge Emilio
AU - Saha, Sunita
AU - Sackey, Helena
AU - Ryu, Jai Min
AU - Ruyssers, Natacha
AU - Russell, Nicola
AU - Rubio, Isabel T.
AU - Rovera, Francesca
AU - Rosset, Laurent
AU - Roshanlall, Chandeena
AU - Rojas, Beatriz
AU - Rocco, Nicola
AU - Roberts, Neill
AU - Riis, Margit
AU - Retamales, Javier
AU - Reinert, Tomas
AU - Redfern, Andrew
AU - Rebaza, Lia
AU - Read, Rebecca
AU - Razis, Evangelia
AU - Ratosa, Ivica
AU - Rao, Smitha
AU - Ramiah, Duvern
AU - Rahim, Ishtiaq Ur
AU - Radhakrishnan, Venkatraman
AU - Putora, Paul Martin
AU - Puchinskaya, Marina
AU - Provenzano, Elena
AU - Moura, Jose Fernando Prado
AU - Portik, Daniel
AU - Porpiglia, Mauro
AU - Poppe, Matthew
AU - Popescu, Razvan
AU - Pogoda, Katarzyna
AU - Piñero-Madrona, Antonio
AU - Segura, Cristina Pérez
AU - Peretz-Yablonski, Tamar
AU - Pellegrini, Alice
AU - Pasquier, David
AU - Pascual, Javier
AU - Papadopoulos, Lazaros
AU - Ferrando, Amparo Oltra
AU - Bagge, Roger Olofsson
AU - Oikonomou, Ira
AU - O’Reilly, Seamus
AU - O’Neill, Conor
AU - Nikopoulou, Angeliki
AU - Nikolic, Dejan
AU - Nguyen, Toan
AU - Narui, Kazutaka
AU - Sánchez, María Alejandra Naranjo
AU - Namiq, Karez
AU - Murawa, Dawid
AU - Munzone, Elisabetta
AU - Migueláñez, Teresa Muñoz
AU - Morgan, Jenna
AU - Montero, Angel
AU - Misra, Shagun
AU - Minisini, Alessandro Marco
AU - Meterissian, Sarkis
AU - Meretoja, Tuomo
AU - Meduri, Bruno
AU - Meattini, Icro
AU - Maulik, Shaurav
AU - Mau, Christine I.
AU - Masuda, Norikazu
AU - Masiello, Valeria
AU - Masannat, Yazan
AU - Martos, Tamara
AU - Martin-Quesada, Ana Isabel
AU - Marti, Covadonga
AU - Martel, Karyne
AU - Marta, Gustavo
AU - Margenthaler, Julie
AU - Marcou, Yiola
AU - Maraldo, Maja
AU - Mantilla, Willam
AU - Mansell, James
AU - Mando, Pablo
AU - Makris, George Marios
AU - Maduro, John
AU - Madeira, Pedro
AU - Macpherson, Iain
AU - Macinnes, Emma
AU - Machiels, Melanie
AU - Luzi, Manjola
AU - Lüftner, Diana
AU - Ludwig, Michelle
AU - Valenti, Elisenda Llabres
AU - Liang, Rhea
AU - Lee, Jeeyeon
AU - Leal, Sara
AU - Laws, Siobhan
AU - Kunkler, Ian
AU - Krug, David
AU - Kretsi, Antigoni
AU - Kontos, Michalis
AU - Konstantis, Apostolos
AU - Konsoulova, Assia
AU - Ko, Hyun Soo
AU - Klein, Evelyn
AU - Kirwan, Cliona
AU - Kipps, Emma
AU - Kihn-Alarcón, Alba
AU - Khan, Mah Muneer
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Accurate information about locoregional breast cancer treatments following neoadjuvant systemic therapy (NST) is essential for meaningful interpretation of oncological outcomes but reporting is currently poor. We developed a core outcome set (COS) to improve the quality and consistency of locoregional outcome reporting in breast cancer NST trials. The COS was developed in three phases according to COS-STAD guidance, with the generation of a list of relevant outcome domains, prioritisation of outcomes through two rounds of an international online multi-stakeholder Delphi survey and a consensus meeting. 159 unique locoregional outcomes were classified into 101 outcome domains for inclusion in the Delphi survey, which was completed by 470 international professionals. The final 15-item COS, which included the pre-NST surgical plan, details of surgery performed following completion of treatment and details of radiation therapy, was agreed at an in-person consensus meeting. Widespread COS implementation will improve the quality and value of future NST trials.
AB - Accurate information about locoregional breast cancer treatments following neoadjuvant systemic therapy (NST) is essential for meaningful interpretation of oncological outcomes but reporting is currently poor. We developed a core outcome set (COS) to improve the quality and consistency of locoregional outcome reporting in breast cancer NST trials. The COS was developed in three phases according to COS-STAD guidance, with the generation of a list of relevant outcome domains, prioritisation of outcomes through two rounds of an international online multi-stakeholder Delphi survey and a consensus meeting. 159 unique locoregional outcomes were classified into 101 outcome domains for inclusion in the Delphi survey, which was completed by 470 international professionals. The final 15-item COS, which included the pre-NST surgical plan, details of surgery performed following completion of treatment and details of radiation therapy, was agreed at an in-person consensus meeting. Widespread COS implementation will improve the quality and value of future NST trials.
UR - https://www.scopus.com/pages/publications/105022312929
U2 - 10.1038/s41523-025-00824-w
DO - 10.1038/s41523-025-00824-w
M3 - Article
C2 - 41152314
AN - SCOPUS:105022312929
SN - 2374-4677
VL - 11
JO - npj Breast Cancer
JF - npj Breast Cancer
IS - 1
M1 - 116
ER -